Coherus Biosciences | CHRS - Cost Of Sales

Coherus Biosciences reported $14.2M in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Acadia Pharmaceuticals ACAD:US USD 2.41M 277K
Akebia Therapeutics AKBA:US USD -11252000 40.93M
ALKERMES ALKS:US USD 53.96M 3.34M
Alnylam Pharmaceuticals ALNY:US USD 51.27M 10.15M
Amarin AMRN:US USD 23.94M 11.87M
Amgen AMGN:US USD 1.75B 159M
Baxter International BAX:US USD 2.42B 208M
Biogen BIIB:US USD 570.9M 101.4M
Biomarin Pharmaceutical BMRN:US USD 127.29M 11M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Coherus Biosciences CHRS:US USD 14.2M 21.03M
Eli Lilly And LLY:US USD 1.55B 31M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Fujifilm 4901:JP JPY 443.26B 5.45B
Gilead Sciences GILD:US USD 1.4B 1000K
Horizon Pharma HZNP:US USD 240.79M 6.65M
JAZZ PHA JAZZ:US USD 167.36M 33.7M
Merk MRK:US USD 3.36B 519M
Myriad Genetics MYGN:US USD 53.9M 3.5M
Pacira Pharmaceuticals PCRX:US USD 61.92M 11.24M
Perrigo Ordinary Shares PRGO:US USD 772.7M 35.4M
Pfizer PFE:US USD 9.82B 3.73B
Ptc Therapeutics PTCT:US USD 10.89M 3.12M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Revance Therapeutics RVNC:US USD 23.52M 12.78M
Sarepta Therapeutics SRPT:US USD 30.8M 9.15M
Teva Pharmaceutical TEVA:IT USD 1.78B 101M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
Zoetis ZTS:US USD 651M 45M